[1] |
张磊, 邵中军. HBV宫内传播研究在乙型肝炎防控工作中发挥着重要的作用. 中华流行病学杂志,2019,40:1055-1058.
|
[2] |
邹怀宾, 赵梦鱼, 陈煜, 等. HBsAg阳性母亲所分娩婴儿完成主被动免疫后的免疫保护效果及其持久性研究. 北京医学, 2019, 41:888-891.
|
[3] |
Amadorcañizares Y, Bernier A, Wilson JA, et al.miR-122 does not impact recognition of the HCV genome by innate sensors of RNA but rather protects the 5' end from the cellular PyroPhosPhatases, DOM3Z and DUSP11. Nucleic Acids Res, 2018, 46:5139-5158.
|
[4] |
宋晓菲, 徐元宏. 丙型肝炎病毒感染患者血清外泌体miR-122的表达量及临床意义探讨. 安徽医科大学学报, 2019, 54:131-134.
|
[5] |
Lu X, Liu Y, Xuan W, et al.Circ1639 induces cells inflammation responses by sponging miR-122 and regulating TNFRSF13C expression in alcoholic liver disease. Toxicol Lett, 2019, 314:89-97.
|
[6] |
Fathi-Kazerooni M, Kazemnejad S, Khanjani S, et al.Down-regulation of miR-122 after transplantation of mesenchymal stem cells in acute liver failure in mice model. Biologicals, 2019, 58:64-72.
|
[7] |
Fournier C, Hoffmann TW, Morel V, et al.Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virus. J Viral Hepat, 2018, 25:63-71.
|
[8] |
张轩, 王淏. 氧化苦参碱对miR-122低表达、感染HBV肝细胞的抗病毒作用观察. 山东医药, 2018, 58:31-33.
|
[9] |
荆晓晴, 姚丽, 谢妍, 等. 乙肝病毒携带者外周血单核细胞miR-122表达与病毒增殖的关系研究. 病毒学报, 2019, 35:895-899.
|
[10] |
熊玉娟, 刘颖异, 庄家玲. miR-122启动子rs7227488单核苷酸多态性及其对HCV易感性研究. 中国输血杂志, 2018, 31:727-731.
|
[11] |
Caviglia GP, Abate ML, Gaia S, et al.Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. Panminerva Med, 2017, 59:283-289.
|
[12] |
van der Ree MH, Jansen L, Kruize Z, et al. Plasma microRNA levels are associated with HBeAg status and treatment response in chronic hepatitis B patients. J Infect Dis, 2017, 215:1421-1429.
|